T2DM | No T2DM | Total | |
---|---|---|---|
OR (95% CI) | OR (95% CI) | OR (95% CI) | |
Time period | 0.8 (0.8–0.9) | 0.8 (0.8–0.9) | 0.8 (0.8–0.9) |
Female sex | 1.3 (1.1–1.6) | NS | 1.2 (1.0–1.3) |
Agea | 1.8 (1.6–2.0) | 1.8 (1.6–2.0) | 1.8 (1.7–2.0) |
Charlson Comorbidity Index | 1.6 (1.5–1.8) | 1.6 (1.5–1.8) | 1.7 (1.5–1.8) |
Acute renal disease | 2.0 (1.6–2.5) | 1.9 (1.5–2.4) | 2.0 (1.7–2.3) |
Ischemic heart disease | 1.3 (1.0–1.6) | NS | NS |
COPD | 0.7 (0.5–0.9) | 0.7 (0.5–0.9) | 0.7 (0.6–0.8) |
Shock | 8.6 (6.1–12.1) | 7.1 (5.0–10.1) | 7.4 (5.8–9.5) |
Dialysis | 2.5 (1.8–3.5) | 1.8 (1.3–2.6) | 2.1 (1.7–2.7) |
Pacemaker implantation | NS | 0.4 (0.2–0.8) | 0.5 (0.3–0.9) |
Mechanical ventilation | 3.3 (2.5–4.4) | 3.7 (2.8–4.8) | 3.4 (2.8–4.1) |
Staphylococcus aureus | NS | NS | 1.2 (1.0–1.5) |
Streptococci | 0.6 (0.5–0.8) | 0.4 (0.3–0.6) | 0.5 (0.4–0.6) |
Enterococci | NS | 0.6 (0.5–0.9) | 0.8 (0.6–0.9) |
Streptococcus pneumoniae | NS | NS | 0.2 (0.0–1.0) |
T2DM | NA | NA | 1.1 (0.9–1.2) |